[1]
Bakay, U. et al. 2026. Hepatic Safety of IL-17 Inhibitors in Psoriasis and Psoriatic Arthritis: A 12-Month Retrospective Cohort Evaluation Using the FIB-4 Index. Dermatology Practical & Conceptual. 16, 1 (Jan. 2026), 6746. DOI:https://doi.org/10.5826/dpc.1601a6746.